Search

everythinglearnresearchcommunity

for

Search:↓

Innovative techniques improve hair transplant results and satisfaction in patients with low donor hair density.

Young adults who had liver disease as children often experience significant health problems and frequently need transplants.

Exosome therapy can safely and effectively restore color to gray hair.

Liquid nitrogen cryotherapy worked well for many patients with stubborn alopecia areata.

Oral minoxidil can improve hair thickness and a comprehensive treatment approach leads to better alopecia outcomes.

Hair transplant surgery by Follicular Unit Extraction is mostly safe and gives good results with few complications.

Permanent eyebrow correction can improve quality of life for those with eyebrow loss.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

FUE successfully restored hair growth in a patient with alopecia from Hansen's disease.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Compounded topical minoxidil works better and is more tolerated than over-the-counter minoxidil for treating hair loss in Black women.

Disease-specific tools better assess quality of life in alopecia areata patients.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Contact immunotherapy can improve hair regrowth in alopecia areata patients.

Injecting platelet-rich plasma during hair transplant surgery improves hair regrowth rate, speeds up skin recovery, and enhances hair quality.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Three patients suffered severe health issues due to not getting enough vitamins and minerals after weight-loss surgery.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Follicular unit extraction successfully restored hair growth in a leprosy patient without disease relapse.

SLE in ageing patients is less severe and needs careful treatment to avoid excess.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Individualized treatment improves symptoms and quality of life for women with PCOS.

Early detection and targeted management are crucial for better outcomes in systemic lupus erythematosus.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Microneedling with CGF significantly improves hair regrowth in androgenetic alopecia.